On ECHEMI
Home > Drugs > Lung cancer
Lung cancer
Lung cancer occurs in the bronchial mucosa or glands, also known as bronchial lung cancer. In the past 50 years, many countries have reported that the incidence of lung cancer has increased significantly. Among male cancer patients, lung cancer has ranked first, and the incidence rate in women has also increased rapidly, accounting for the second or third most common malignant tumors in women. The male-female incidence ratio is 3~5:1, and the age of onset is mostly between 60-79 years old. The cause of lung cancer is still not completely clear. A large amount of data shows that long-term heavy smoking is an important pathogenic factor of lung cancer. For those who smoke more than 40 cigarettes a day for many years, the incidence of squamous cell carcinoma and undifferentiated cancer of the lung is 4 to 10 times higher than that of non-smokers. The incidence of lung cancer in urban residents is higher than that in rural areas, which may be related to air pollution and carcinogens contained in smoke. Therefore, non-smoking should be advocated and urban environmental sanitation work should be strengthened.
Related Drugs
Iris capsules
Indication: This product is a radiosensitizer used in radiotherapy for lung cancer, esophageal cancer, head and neck cancer, etc.
Manufacturer:

Shandong Xinhua Pharmaceutical Company Limited

Iris capsules
Indication: This product is a radiosensitizer used in radiotherapy for lung cancer, esophageal cancer, head and neck cancer, etc.
Manufacturer:

Shandong Xinhua Pharmaceutical Company Limited

Kanglaite Injection
Manufacturer:

Zhejiang Kanglaite Pharmaceutical Co., Ltd.

Xiaoaiping injection
Manufacturer:

Tonghua Golden-Horse Pharmaceutical Industey Co., Ltd.

Xiaoaiping injection
Manufacturer:

Nanjing Sanhome Pharmaceutical Co., Ltd.

Jinfukang oral liquid
Manufacturer:

Jilin Sanjiu Jinfukang Pharmaceutical Co., Ltd.

Lobaplatin
Indication: This product is mainly used to treat breast cancer, small cell lung cancer and chronic myeloid leukemia.
Manufacturer:

Hainan Changan International Pharmaceutical Co., Ltd.

Lobaplatin for injection
Indication: Treatment of inoperable metastatic breast cancer; treatment of inoperable transformed small cell lung cancer; treatment of chronic myeloid leukemia
Manufacturer:

Hainan Changan International Pharmaceutical Co., Ltd.

Lobaplatin for injection
Indication: Treatment of inoperable metastatic breast cancer; treatment of inoperable transformed small cell lung cancer; treatment of chronic myeloid leukemia
Manufacturer:

Hainan Changan International Pharmaceutical Co., Ltd.

Uropolyacitide injection
Indication: Combined with chemotherapy, it can be used for adjuvant treatment of advanced breast cancer and non-small cell lung cancer.
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.